We are live on ! Find out more
Vanguard Group

Vanguard Group Portfolio holdings

AUM $6.9T
1-Year Est. Return 27.45%
 

The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.

This Fund
S&P 500
This Quarter Est. Return
+6.66%
1 Year Est. Return
+27.45%
3 Year Est. Return
+121.04%
5 Year Est. Return
+156.26%
10 Year Est. Return
+538.57%
AUM
$2.29T
AUM Growth
+$147B
Cap. Flow
+$28.3B
Cap. Flow %
1.24%
Top 10 Hldgs %
14.11%
Holding
4,176
New
102
Increased
2,933
Reduced
915
Closed
113

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$1.56B
2
INVH icon
Invitation Homes
INVH
+$932M
3
MSFT icon
Microsoft
MSFT
+$818M
4
LUMN icon
Lumen
LUMN
+$746M
5
BDX icon
Becton Dickinson
BDX
+$706M

Sector Composition

Rank Sector Weight
1 Financials 15.99%
2 Technology 15.47%
3 Healthcare 12.33%
4 Industrials 10.79%
5 Consumer Discretionary 9.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FLXN
2226
DELISTED
Flexion Therapeutics, Inc.
FLXN
$36.5M ﹤0.01%
1,458,808
+319,874
+28% +$7.83M
WAIR
2227
DELISTED
WESCO Aircraft Holdings Inc.
WAIR
$36.3M ﹤0.01%
4,904,950
+296,276
+6% +$2.45M
SCCO icon
2228
Southern Copper
SCCO
$143B
$36.3M ﹤0.01%
824,242
-20,761
-2% -$834K
EOCC
2229
DELISTED
Enel Generacion Chile S.A.
EOCC
$36.2M ﹤0.01%
1,346,131
-102,425
-7% -$2.68M
LXRX icon
2230
Lexicon Pharmaceuticals
LXRX
$1.03B
$36M ﹤0.01%
3,639,925
+83,164
+2% +$864K
TVTX icon
2231
Travere Therapeutics
TVTX
$5.2B
$35.9M ﹤0.01%
1,703,290
+16,446
+1% +$376K
CRC
2232
DELISTED
California Resources Corporation
CRC
$35.7M ﹤0.01%
1,834,192
-67,288
-4% -$944K
UTL icon
2233
Unitil
UTL
$970M
$35.6M ﹤0.01%
779,763
+14,192
+2% +$712K
PDLI
2234
DELISTED
PDL BioPharma, Inc.
PDLI
$35.5M ﹤0.01%
12,955,201
+491,368
+4% +$1.51M
LILAK icon
2235
Liberty Latin America Class C
LILAK
$1.63B
$35.5M ﹤0.01%
2,083,422
+28,372
+1% +$534K
PFBC icon
2236
Preferred Bank
PFBC
$1.24B
$35.5M ﹤0.01%
603,370
+19,146
+3% +$1.16M
SPOK icon
2237
Spok Holdings
SPOK
$228M
$35.4M ﹤0.01%
2,263,920
-110,314
-5% -$1.85M
NTLA icon
2238
Intellia Therapeutics
NTLA
$1.49B
$35.3M ﹤0.01%
1,836,481
+791,188
+76% +$18.3M
RMR icon
2239
The RMR Group
RMR
$325M
$35.3M ﹤0.01%
595,168
+24,160
+4% +$1.36M
CMCO icon
2240
Columbus McKinnon
CMCO
$553M
$35.3M ﹤0.01%
882,489
+10,945
+1% +$419K
CNOB icon
2241
Center Bancorp
CNOB
$1.66B
$35.2M ﹤0.01%
1,367,530
+8,350
+0.6% +$219K
TCBK icon
2242
TriCo Bancshares
TCBK
$1.84B
$35.2M ﹤0.01%
930,010
+34,245
+4% +$1.41M
FF icon
2243
Future Fuel
FF
$217M
$35.2M ﹤0.01%
2,498,457
+110,369
+5% +$1.64M
TCRT icon
2244
Alaunos Therapeutics
TCRT
$4.59M
$35.2M ﹤0.01%
56,616
+2,035
+4% +$1.46M
ONC
2245
BeOne Medicines Ltd
ONC
$32.8B
$35.1M ﹤0.01%
358,829
+247,947
+224% +$22.7M
ONTO icon
2246
Onto Innovation
ONTO
$12.9B
$35M ﹤0.01%
1,404,330
+20,212
+1% +$538K
SUP
2247
DELISTED
Superior Industries International
SUP
$35M ﹤0.01%
2,354,587
+139,401
+6% +$2.23M
AXDX
2248
DELISTED
Accelerate Diagnostics
AXDX
$34.9M ﹤0.01%
133,311
+4,363
+3% +$1.02M
SRCE icon
2249
1st Source
SRCE
$2.16B
$34.8M ﹤0.01%
704,577
-19,305
-3% -$980K
HSKA
2250
DELISTED
Heska Corp
HSKA
$34.8M ﹤0.01%
434,302
-67,605
-13% -$5.96M

Similar funds

Vanguard Group's Q4 2017 Portfolio in Review

As of Q4 2017, Vanguard Group held 4,176 positions worth $2.29T, up 6.9% from $2.14T the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Vanguard Group's Q4 2017 filing shows 102 new, 2,933 increased, 915 reduced and 113 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 7,351,313 shares worth $386M. The largest sale was CR Bard Inc., an estimated $2.53B.

By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • Vanguard Group's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 7,351,313 shares worth $386M.
  • Vanguard Group added most to Alibaba in Q4 2017, an estimated $1.56B increase.
  • Vanguard Group's biggest Q4 2017 reduction was Lam Research, cutting an estimated $452M.
  • Vanguard Group fully exited CR Bard Inc. in Q4 2017, selling an estimated $2.53B.
  • Vanguard Group's ten largest holdings make up 14% of its $2.29T portfolio in Q4 2017.
  • Vanguard Group opened 102 new positions and closed 113 in Q4 2017.
  • Vanguard Group's portfolio value rose 6.9% quarter-over-quarter to $2.29T.

Based on Vanguard Group's 13F filing for Q4 2017, filed 14 Feb 2018.